Life Science Reit (LABS) Tightens Dividend Policy: Rebasing to Ensure Sustainable Growth in Challenging Market Conditions

Life Science Reit cuts dividend due to economic uncertainties affecting rollout速Life Science Reit reduces dividend payout amidst economic challenges hindering expansion efforts

Life Science Reit (LABS) announced that it will be cutting its dividends for 2023. The dividends will be halved to 2p per share, with the second payment for the year decreased from 3p to 1p per share. Despite reporting good progress during the past year, LABS cited economic uncertainty, occupiers postponing rental decisions, and high interest rates as factors contributing to the difficult decision to rebase the dividend.

The goal behind this move is to ensure that the dividend is covered by earnings and can grow sustainably from this new level. LABS believes that by reducing its dividends, it will have more financial flexibility to deliver on its strategy in a challenging market environment. This adjustment will also enable the fund to better navigate current economic landscape and continue working towards its long-term objectives.

Although LABS has had to make tough choices in order to maintain its financial stability, it remains optimistic about its future prospects. The fund is focused on creating value for shareholders in the years ahead and continuing to progress towards its long-term goals despite necessary changes in its dividend policy.

Life Science Reit (LABS) announced that it will be cutting its dividends for 2023. The dividends will be halved to 2p per share, with the second payment for the year decreased from 3p to 1p per share. Despite reporting good progress during the past year, LABS cited economic uncertainty, occupiers postponing rental decisions, and high…

Leave a Reply